Enterolactone mitigates atherosclerosis by facilitating resolution of ferroptosis-associated intimal inflammation via the Keap1/Nrf2/GPX4 pathway
Phytomedicine · 2026-06 · 155 · 158178
DOI: 10.1016/j.phymed.2026.158178 ↗Kurz gefasst
Fachartikel in der Zeitschrift Phytomedicine, 2026-06. Verfasst von Shuhui Chai und 19 weiteren Autor:innen. Beteiligte Einrichtung: Genomics Research Center (Key Laboratory of Gut Microbiota and Pharmacogenomics of Heilongjiang Province, State-Province Key Laboratory of Biomedicin…. Hauptthemen laut MEDLINE: Lignans, Atherosclerosis, Kelch-Like ECH-Associated Protein 1, 4-Butyrolactone. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 61 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Harbin Medical University, Natural Science Foundation of Heilongjiang Province.
Abstract (Originalsprache)
BACKGROUND: Atherosclerosis is the inflammatory consequence of lipid accumulation with plaque formation in the vascular intima and is a common condition to develop into various cardiovascular diseases. Current therapies do not always lead to satisfactory treatment outcomes. Enterolactone, a mammalian lignan produced by bacterial transformation from plant lignans, has a preventive effect against cardiovascular disease. However, its effect on atherosclerosis and the underlying mechanism of action remain unclear. PURPOSE: To explore the therapeutic effect of ENL on atherosclerosis and elucidate the underlying mechanism. METHODS: We established a model of atherosclerosis on ApoE-/- C57BL/6 mice by high fat diet. The aortic root was collected and sectioned to assess arterial plaque area, collagen fibrillar proliferation, and lipid content. RT-qPCR was used to determine the inflammatory response in the artery of mice. The serum from mice was isolated to measure lipid levels, and the fecal microbiota was analyzed by 16S rDNA. H2O2 was used to induce HUVEC injury and ferroptosis to mimic endothelial cell dysfunction in atherosclerosis, and the inhibitory effect of ENL on HUVEC ferroptosis was appraised by monitoring ferroptosis indexes and levels of iron-related proteins. RESULTS: In the animals, enterolactone significantly improved lipid metabolism, attenuated ferroptosis occurring in the intima, facilitated the antioxidant mechanisms, and promoted healing of the endothelial lesions, by interacting with Nrf2. Of great importance, enterolactone massively altered the gut microbiota toward a curative outcome by elevating the abundance of beneficial bacteria, such as the SCFA-producing taxa. Additionally, ENL suppresses lipid peroxidation and inflammatory activation in HUVECs by regulating the Keap1/Nrf2/GPX4 pathway, and knocking down Nrf2 attenuates the treatment effect of ENL. CONCLUSION: Enterolactone effectively resolves intimal inflammation and redresses atherosclerosis by ameliorating the gut microbiome and modulating lipid metabolism via the Keap1/Nrf2/GPX4 pathway.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Genomics Research Center (Key Laboratory of Gut Microbiota and Pharmacogenomics of Heilongjiang Province, State-Province Key Laboratory of Biomedicine-Pharmaceutics of China), College of Pharmacy, Harbin Medical Univers…
- Department of Pharmacology, College of Pharmacy, Harbin Medical University, Harbin 150081, China.
- State Key Laboratory of Frigid Zone Cardiovascular Diseases, Harbin 150081, China; Department of Pharmacology, College of Pharmacy, Harbin Medical University, Harbin 150081, China. Electronic address: bantao2000@163.com.
Förderung
- National Natural Science Foundation of China
- Harbin Medical University
- Natural Science Foundation of Heilongjiang Province
- China Postdoctoral Science Foundation
Zitieren
APA
Chai, S., Zhang, Y., Guo, Y., Cao, D., Wang, J., Yan, Y., Shi, Y., Yuan, Z., Wang, X., Tong, T., Zhen, Z., Huo, Y., Zhang, K., Wang, F., Liu, G. R., Li, W., Xu, X., Ban, T., Liu, S. L., & Liu, H. (2026). Enterolactone mitigates atherosclerosis by facilitating resolution of ferroptosis-associated intimal inflammation via the Keap1/Nrf2/GPX4 pathway. Phytomedicine, 155, 158178. https://doi.org/10.1016/j.phymed.2026.158178
Vancouver
Chai S, Zhang Y, Guo Y, Cao D, Wang J, Yan Y, et al. Enterolactone mitigates atherosclerosis by facilitating resolution of ferroptosis-associated intimal inflammation via the Keap1/Nrf2/GPX4 pathway. Phytomedicine. 2026;155:158178. doi:10.1016/j.phymed.2026.158178
BibTeX
@article{Chai2026,
author = {Chai, Shuhui and Zhang, Yihang and Guo, Yi and Cao, Danli and Wang, Jiaxing and Yan, Yu and Shi, Yuxue and Yuan, Zhiyi and Wang, Xiaoyu and Tong, Tingting and Zhen, Ziyi and Huo, Yanhao and Zhang, Kaiwen and Wang, Fenglin and Liu, Gui-Rong and Li, Weiheng and Xu, Xiaohui and Ban, Tao and Liu, Shu-Lin and Liu, Huidi},
title = {Enterolactone mitigates atherosclerosis by facilitating resolution of ferroptosis-associated intimal inflammation via the Keap1/Nrf2/GPX4 pathway},
journal = {Phytomedicine},
year = {2026},
volume = {155},
pages = {158178},
doi = {10.1016/j.phymed.2026.158178}
}
EUVIMED